Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TEVA | Teva Pharmaceutical Industries Limited

Index- P/E- EPS (ttm)-2.00 Insider Own- Shs Outstand1.12B Perf Week-2.27%
Market Cap11.56B Forward P/E4.21 EPS next Y2.46 Insider Trans- Shs Float1.11B Perf Month6.26%
Income-2233.00M PEG- EPS next Q0.62 Inst Own49.60% Short Float / Ratio1.52% / 1.77 Perf Quarter35.83%
Sales15.02B P/S0.77 EPS this Y-662.70% Inst Trans9.29% Short Interest16.90M Perf Half Y21.34%
Book/sh6.30 P/B1.64 EPS next Y7.40% ROA-5.10% Target Price10.22 Perf Year25.91%
Cash/sh2.39 P/C4.33 EPS next 5Y1.60% ROE-28.30% 52W Range7.09 - 11.44 Perf YTD13.49%
Dividend- P/FCF9.85 EPS past 5Y34.30% ROI-5.00% 52W High-9.57% Beta1.14
Dividend %- Quick Ratio0.70 Sales past 5Y-7.80% Gross Margin49.10% 52W Low46.08% ATR0.26
Employees34004 Current Ratio1.00 Sales Q/Q2.40% Oper. Margin-7.20% RSI (14)59.60 Volatility2.53% 2.25%
OptionableYes Debt/Eq2.93 EPS Q/Q-268.70% Profit Margin-14.90% Rel Volume0.69 Prev Close10.34
ShortableYes LT Debt/Eq2.65 EarningsAug 02 BMO Payout- Avg Volume9.54M Price10.35
Recom2.80 SMA203.75% SMA509.99% SMA20014.39% Volume6,587,335 Change0.10%
Date Action Analyst Rating Change Price Target Change
Jul-06-23Upgrade UBS Sell → Neutral $7 → $8
May-25-23Initiated Morgan Stanley Equal-Weight $10
May-18-23Upgrade Evercore ISI In-line → Outperform
Jan-19-23Downgrade Jefferies Buy → Hold $10 → $12
Nov-14-22Downgrade JP Morgan Neutral → Underweight $11 → $10
Nov-04-22Downgrade UBS Neutral → Sell
Oct-21-22Resumed Jefferies Buy $10
Aug-05-22Upgrade BofA Securities Neutral → Buy $10 → $13
Jun-14-22Resumed UBS Neutral $10
May-17-22Upgrade BofA Securities Underperform → Neutral $9
Sep-20-23 07:34PM
Sep-13-23 05:21AM
Sep-06-23 04:30PM
08:00AM
Sep-01-23 12:04AM
11:02AM Loading…
Aug-31-23 11:02AM
Aug-23-23 03:49AM
Aug-22-23 01:22PM
09:19AM
Aug-21-23 07:27PM
06:48PM
04:32PM
04:12PM
04:09PM
04:00PM
05:54AM Loading…
Aug-15-23 05:54AM
Aug-14-23 07:01AM
Aug-11-23 10:33AM
Aug-03-23 12:45PM
12:41PM
11:22AM
Aug-02-23 11:26PM
08:21PM
05:20PM
04:01PM
01:40PM
11:49AM
11:00AM
10:30AM
09:00AM
07:40AM Loading…
07:40AM
07:21AM
07:18AM
07:00AM
Jul-31-23 07:35AM
07:20AM
Jul-27-23 08:00AM
Jul-24-23 03:06PM
04:00AM
Jul-06-23 09:54AM
03:32AM
Jul-05-23 05:38PM
04:30PM
Jun-30-23 12:30PM
Jun-28-23 02:54PM
Jun-24-23 03:19PM
Jun-17-23 06:10AM
Jun-15-23 08:00AM
Jun-12-23 04:00PM
07:00AM
03:00AM
Jun-09-23 02:08PM
Jun-08-23 12:15PM
08:30AM
Jun-07-23 05:15PM
Jun-06-23 08:00AM
Jun-05-23 10:00AM
Jun-02-23 04:30PM
May-29-23 09:51AM
May-25-23 10:15AM
May-24-23 04:34AM
May-23-23 08:01AM
May-21-23 01:54PM
May-20-23 11:00AM
May-18-23 03:22PM
02:37PM
11:59AM
09:12AM
08:30AM
May-15-23 09:49AM
09:45AM
08:00AM
May-11-23 09:33AM
May-10-23 04:02PM
11:00AM
09:30AM
09:15AM
07:00AM
May-09-23 03:57PM
07:00AM
May-05-23 02:01PM
02:01PM
May-04-23 11:23AM
May-03-23 08:30AM
May-01-23 01:08PM
10:38AM
Apr-29-23 09:53PM
Apr-28-23 08:22PM
07:22PM
Apr-27-23 08:35AM
Apr-19-23 11:49AM
Apr-15-23 08:56AM
Apr-14-23 04:15PM
01:53PM
09:40AM
Apr-13-23 08:53PM
Apr-12-23 02:32PM
10:46AM
Apr-11-23 08:00AM
Apr-05-23 08:00AM
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kalif Eliyahu SharonEVP, Chief Financial OfficerAug 07Sale9.7335,125341,88999,162Aug 09 04:02 PM
Weiss AmirChief Accounting OfficerAug 04Sale9.921,98119,65842,442Aug 07 04:15 PM
Hughes Eric ASee "Remarks"Aug 01Sale8.3052,742437,6900Aug 03 07:09 AM
Dethlefs SvenEVP, North America CommercialMar 07Sale9.4358,066547,440165,381Mar 08 04:03 PM
Daniell RichardExec. VP, European CommercialMar 07Sale9.4354,007509,17369,770Mar 08 04:02 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 07Sale9.4349,475466,4452,974Mar 08 04:05 PM
Drape EricExecutive VP Global OperationsMar 07Sale9.434,69944,302173,262Mar 08 04:04 PM
Dethlefs SvenEVP, North America CommercialMar 06Sale9.9319,355192,213223,447Mar 08 04:03 PM
Daniell RichardExec. VP, European CommercialMar 06Sale9.9318,002178,776123,777Mar 08 04:02 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 06Sale9.9316,491163,77052,449Mar 08 04:05 PM
Drape EricExecutive VP Global OperationsMar 06Sale9.931,56615,552177,961Mar 08 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 28Sale9.8963,383626,6422,974Mar 02 07:38 AM
Dethlefs SvenEVP, North America CommercialFeb 28Sale9.8959,655589,785165,381Mar 02 07:33 AM
Daniell RichardExec. VP, European CommercialFeb 28Sale9.8944,252437,50243,182Mar 02 07:33 AM
Drape EricExecutive VP Global OperationsFeb 28Sale9.8933,685333,03087,789Mar 02 07:34 AM